Cargando…

Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer’s Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort

BACKGROUND: Neuroinflammation is a central component of Alzheimer’s disease (AD) and correlates closely with amyloid pathology. Markers of inflammation such as cytokines, and amyloidogenic aggregates, so-called nanoplaques, are both promising biomarker candidates for AD. We have previously shown tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aksnes, Mari, Aass, Hans Christian D., Tiiman, Ann, Terenius, Lars, Bogdanović, Nenad, Vukojević, Vladana, Knapskog, Anne-Brita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108575/ https://www.ncbi.nlm.nih.gov/pubmed/35213378 http://dx.doi.org/10.3233/JAD-215504

Ejemplares similares

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
por: Aksnes, Mari, et al.
Publicado: (2021)

Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
por: Aksnes, Mari, et al.
Publicado: (2021)

Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer’s Disease in a Memory Clinic Cohort
por: Aksnes, Mari, et al.
Publicado: (2020)

Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer’s Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis
por: Tiiman, Ann, et al.
Publicado: (2019)

Small Molecule Decoys of Aggregation for Elimination of Aβ-Peptide Toxicity
por: Oasa, Sho, et al.
Publicado: (2023)

Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
por: Müller, Ebba Gløersen, et al.
Publicado: (2019)

The interwoven fibril-like structure of amyloid-beta plaques in mouse brain tissue visualized using super-resolution STED microscopy
por: Johansson, Björn, et al.
Publicado: (2023)

Iso-α-acids in Nonalcoholic and Alcoholic Beer Stimulate Growth of Neuron-like SH-SY5Y Cells and Neuroepithelial Stem Cells
por: Laurent, Agneta J., et al.
Publicado: (2021)

Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease
por: Aksnes, Mari, et al.
Publicado: (2023)

Ethanol/Naltrexone Interactions at the mu-Opioid Receptor. CLSM/FCS Study in Live Cells
por: Vukojević, Vladana, et al.
Publicado: (2008)

A strategy for designing allosteric modulators of transcription factor dimerization
por: Oasa, Sho, et al.
Publicado: (2020)

Smallest Secondary Nucleation Competent Aβ Aggregates Probed by an ATP-Independent Molecular Chaperone Domain
por: Leppert, Axel, et al.
Publicado: (2021)

Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT(1A)) Receptors Heterodimerization and Cellular Effectors (Ca(2+), ERK1/2 and p38) Activation
por: Radoi, Vlad, et al.
Publicado: (2022)

Nanoscale Effects of Ethanol and Naltrexone on Protein Organization in the Plasma Membrane Studied by Photoactivated Localization Microscopy (PALM)
por: Tobin, Steven J., et al.
Publicado: (2014)

Control of Hox transcription factor concentration and cell-to-cell variability by an auto-regulatory switch
por: Papadopoulos, Dimitrios K., et al.
Publicado: (2019)

Mapping the Direction of Nucleocytoplasmic Transport of Glucocorticoid Receptor (GR) in Live Cells Using Two-Foci Cross-Correlation in Massively Parallel Fluorescence Correlation Spectroscopy (mpFCS)
por: Nikolić, Stanko N., et al.
Publicado: (2023)

Conformation‐specific antibodies against multiple amyloid protofibril species from a single amyloid immunogen
por: Bonito‐Oliva, Alessandra, et al.
Publicado: (2019)

Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane
por: Terenius, Lars, et al.
Publicado: (2023)

Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
por: Zhao, Jing, et al.
Publicado: (2020)

Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability?
por: Waragai, Masaaki, et al.
Publicado: (2020)

Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics
por: Eldholm, Rannveig Sakshaug, et al.
Publicado: (2018)

Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
por: Knapskog, Anne-Brita, et al.
Publicado: (2017)

Dynamic Cellular Cartography: Mapping the Local Determinants of Oligodendrocyte Transcription Factor 2 (OLIG2) Function in Live Cells Using Massively Parallel Fluorescence Correlation Spectroscopy Integrated with Fluorescence Lifetime Imaging Microscopy (mpFCS/FLIM)
por: Oasa, Sho, et al.
Publicado: (2021)

Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease
por: He, Hongwen, et al.
Publicado: (2010)

Connecting Alzheimer’s Disease With Diabetes Mellitus Through Amyloidogenic Evolvability
por: Ho, Gilbert, et al.
Publicado: (2020)

A Super-Resolved View of the Alzheimer’s Disease-Related Amyloidogenic Pathway in Hippocampal Neurons
por: Yu, Yang, et al.
Publicado: (2021)

Multi-compartmental modeling of SORLA’s influence on amyloidogenic processing in Alzheimer’s disease
por: Lao, Angelyn, et al.
Publicado: (2012)

Protective Effects of Wogonin against Alzheimer's Disease by Inhibition of Amyloidogenic Pathway
por: Huang, Ding-Siang, et al.
Publicado: (2017)

Alteration in synaptic nanoscale organization dictates amyloidogenic processing in Alzheimer's disease
por: Kedia, Shekhar, et al.
Publicado: (2020)

Reconsideration of Alzheimer’s Disease Therapy from a Viewpoint of Amyloidogenic Evolvability
por: Ho, Gilbert, et al.
Publicado: (2022)

Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp120
por: Lee, Young-Jung, et al.
Publicado: (2021)

Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
por: Ehehalt, Robert, et al.
Publicado: (2003)

Dual roles of Aβ in proliferative processes in an amyloidogenic model of Alzheimer’s disease
por: Baglietto-Vargas, David, et al.
Publicado: (2017)

Neuroprotective, Anti-Amyloidogenic and Neurotrophic Effects of Apigenin in an Alzheimer’s Disease Mouse Model
por: Zhao, Le, et al.
Publicado: (2013)

Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins
por: Kulichikhin, Konstantin Y., et al.
Publicado: (2021)

Is Amyloid Burden Measured by (18)F-Flutemetamol PET Associated with Progression in Clinical Alzheimer’s Disease?
por: Müller, Ebba Gløersen, et al.
Publicado: (2022)

Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort
por: Tangen, Gro Gujord, et al.
Publicado: (2023)

VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival
por: Religa, Piotr, et al.
Publicado: (2013)

Diagnostic accuracy of brain age prediction in a memory clinic population and comparison with clinically available volumetric measures
por: Persson, Karin, et al.
Publicado: (2023)

GPR37 and GPR37L1 differently interact with dopamine 2 receptors in live cells
por: Hertz, E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bj3j6ioab7qvhqjanb9jr3sm88